German Pharma Stock News

In late December 2025, flatexDEGIRO changed its legal form and that of flatexDEGIRO Bank from a German stock corporation (AG) to a Societas Europaea (SE), while also expanding its Group Management Board and appointing long-serving executive Jens Möbitz as Chief Operating Officer from January 1, 2026. This shift to an SE structure, combined with strengthening operational leadership in banking and IT, signals an effort to streamline governance across the group and prepare for the planned...

Merck KGaA, Darmstadt, Germany recently reported that China’s NMPA has granted Priority Review approval for pimicotinib, a CSF-1R inhibitor, to treat adult patients with symptomatic tenosynovial giant cell tumor where surgery risks functional limitation or relatively severe morbidity. This first Chemical Drug Class 1 approval in China for TGCT, backed by strong Phase 3 MANEUVER data, adds a differentiated rare-disease therapy to Merck KGaA’s healthcare portfolio in a major market. We’ll now...

Without a clear single catalyst in focus, Allianz (XTRA:ALV) is drawing attention as investors reassess its recent share performance, income profile, and business scale across insurance and asset management activities. See our latest analysis for Allianz. Allianz’s share price at €387.7 has had a relatively steady few weeks, with a 30 day share price return of 5.73% and a 90 day share price return of 6.42%, while the 1 year total shareholder return of 35.26% and 3 year total shareholder...

Snowflake partnership sets fresh context for SAP shares SAP (XTRA:SAP) is in focus after announcing a collaboration that links Snowflake’s AI Data Cloud with SAP Business Data Cloud, aiming to simplify data sharing and AI driven insights for enterprise customers. See our latest analysis for SAP. Despite the Snowflake tie up, SAP’s recent 1 day, 7 day and 90 day share price returns of 3.07%, 3.12% and 14.06% declines suggest fading short term momentum. However, its 3 year total shareholder...

Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...

Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...

The European market has been buoyed by an improving economic backdrop, with the STOXX Europe 600 Index reaching new highs and closing 2025 with its strongest yearly performance since 2021. Against this optimistic landscape, identifying small-cap stocks that exhibit robust fundamentals and growth potential can be particularly rewarding for investors seeking to capitalize on the region's momentum.

Infineon Technologies AG's ( ETR:IFX ) price-to-earnings (or "P/E") ratio of 50.5x might make it look like a strong...

Key Insights Hannover Rück's significant private companies ownership suggests that the key decisions are influenced by...

Key Insights Aurubis' estimated fair value is €190 based on 2 Stage Free Cash Flow to Equity Aurubis is estimated to be...

If you are wondering whether Bayer at around €38.00 is still offering value after a strong run, this article will walk through what the current price actually reflects. Bayer's share price shows a mixed return profile, with a 4.4% move over 7 days, 14.1% over 30 days, 93.6% over 1 year, and longer term returns of a 23.0% decline over 3 years and a 16.0% decline over 5 years. Recent news around Bayer has focused on its ongoing portfolio and restructuring efforts as well as continued attention...

As the European markets continue to thrive, with the STOXX Europe 600 Index reaching new highs and closing 2025 with impressive gains, investors are increasingly looking for opportunities within this robust economic environment. In such a context, identifying stocks that may be trading below their intrinsic value can provide potential avenues for growth, particularly when these stocks are supported by strong fundamentals and positive market conditions.

Key Insights CTS Eventim KGaA's significant insider ownership suggests inherent interests in company's expansion The...

Friedrich Vorwerk Group SE's ( ETR:VH2 ) price-to-earnings (or "P/E") ratio of 23.9x might make it look like a sell...

Many investors define successful investing as beating the market average over the long term. But the risk of stock...

If you're looking for a multi-bagger, there's a few things to keep an eye out for. Typically, we'll want to notice a...

With a median price-to-sales (or "P/S") ratio of close to 0.6x in the Chemicals industry in Germany, you could be...

PUMA SE ( ETR:PUM ), is not the largest company out there, but it led the XTRA gainers with a relatively large price...

The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...

Munich Re AG has appointed Eric Zhao as chief executive officer of its Beijing branch, effective January 1, 2026, succeeding Adrian Goh, who moved to become chief risk officer APAC/MEA from February 1, 2026. This leadership reshuffle concentrates regional expertise in both on-the-ground China operations and broader risk oversight, which can influence Munich Re’s approach to growth and risk management across Asian and Middle Eastern markets. We’ll now examine how Eric Zhao’s leadership in...

Siemens share performance sets the stage Siemens (XTRA:SIE) has climbed about 3 % over the past month and 28 % over the past year, a steady move that invites a closer look at whether the current valuation still leaves upside. See our latest analysis for Siemens. That climb reflects investors steadily rewarding Siemens for its improving fundamentals, with a 1 year total shareholder return near 28 % signalling firm momentum even as the 3 month share price return has paused around the recent...

Key Insights Significant control over Knorr-Bremse by private companies implies that the general public has more power...

It is hard to get excited after looking at Scout24's (ETR:G24) recent performance, when its stock has declined 19% over...

When you see that almost half of the companies in the Leisure industry in Germany have price-to-sales ratios (or "P/S...